Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-29

Clinical Trial Update: A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache

View source ↗

Summary

A completed Mayo Clinic study evaluating biomarker signatures to predict the persistence of post-traumatic headache. The study included healthy participants as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Post-Traumatic Headache, Healthy | Status: COMPLETED